Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing submucosal dexamethasone to methylprednisolone for postoperative sequelae after parasymphysis mandible fractures is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Nishtar Medical University | Conditions: Mandible Fracture, Edema Face | Phase 2 | Status: RECRUITING